Jupiter Life Line Hospitals Limited

NSE: JLHL · Unclassified

₹287.60+0.37%06 Nov 2026

Ask the data

Instant answers about Jupiter Life Line Hospitals Limited — computed from its filings, no language model

Market cap₹9,428 cr

Current price₹287.60

High / Low₹332 / ₹240

P/E50.5

P/B5.78

Book value₹49.7

ROE11.5%

ROCE13.2%

Debt / equity0.36

Dividend yield0.07%

EPS (TTM)₹5.70

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY24	FY25	FY26
Revenue	1,070	1,262	1,500
EBITDA	238	297	343
Operating margin	22.3%	23.5%	22.9%
Interest	26	11	33
Depreciation	42	57	88
Profit before tax	195	258	265
Tax	19	64	66
Net profit	0	193	194
EPS ₹	28.65	29.47	29.59
Operating cash flow	115	253	268
Capex	85	321	502
Dividend paid	6	7	7
Total assets	1,281	1,905	2,383
Equity	1,169	1,356	1,544

Quarterly performance

last 14 quarters · ₹ crore

showing latest 8 of 14 periods

	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	243	263	273	290	287	323	321	327	348	394	365	388	411	456
Operating profit	53	61	62	62	64	75	75	78	78	92	83	89	79	107
Operating margin	21.8%	23.2%	22.7%	21.4%	22.2%	23.2%	23.4%	23.9%	22.5%	23.4%	22.8%	23.0%	19.3%	23.4%
Other income	5	4	8	9	8	9	8	7	13	11	9	9	11	11
Interest	12	12	1	1	1	1	3	6	8	8	8	9	13	14
Depreciation	11	11	11	10	11	14	14	18	21	21	22	23	26	28
Profit before tax	34	41	58	62	60	69	67	62	62	74	57	66	51	75
Tax	-20	8	14	17	16	17	14	17	18	17	14	17	13	19
Net profit	0	34	44	0	0	0	53	45	44	57	43	51	37	56
EPS ₹	9.93	5.67	6.56	6.49	6.80	7.86	8.01	6.84	6.69	8.75	6.49	7.66	5.72	1.72
Revenue YoY	—	—	—	—	18.0%	22.6%	17.6%	12.5%	21.1%	22.0%	14.0%	18.7%	18.2%	16.0%
Profit YoY	—	—	—	—	—	-100.0%	20.2%	—	—	—	-19.0%	12.8%	-14.5%	-2.1%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 11 periods

	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	6.6%	6.6%	3.5%	4.2%	7.2%	10.4%	13.7%	13.0%	12.6%	12.2%	11.5%
ROCE	19.0%	20.3%	20.1%	21.0%	15.9%	16.5%	16.2%	15.9%	14.2%	13.9%	13.2%
Net margin	7.2%	6.9%	3.7%	4.3%	7.7%	10.7%	14.3%	13.2%	13.0%	12.1%	11.5%
EBITDA margin	22.3%	22.4%	22.4%	22.6%	23.2%	23.3%	23.3%	23.2%	22.9%	22.1%	22.1%
Debt / equity	0.00	0.00	0.00	0.00	0.24	0.24	0.23	0.23	0.33	0.33	0.36
Interest coverage	8.42	15.52	60.94	44.62	25.43	15.61	11.81	9.72	8.92	7.65	6.75
Asset turnover	0.83	0.87	0.84	0.88	0.66	0.69	0.69	0.71	0.63	0.65	0.63

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 7 periods

	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	66	66	66	66	66	66	66
Other equity / reserves	1,015	1,103	1,193	1,291	1,385	1,479	1,565
Total equity	1,081	1,169	1,258	1,356	1,451	1,544	1,630
Borrowings	3	0	0	326	333	509	589
Current liabilities	143	106	129	152	174	227	246
Non-current liabilities	2	7	7	396	398	612	683
Total assets	1,226	1,281	1,394	1,905	2,023	2,383	2,560
Property, plant & equipment	715	716	748	973	993	1,376	1,321
Capital work-in-progress	39	74	135	185	296	129	194
Investments	2	17	83	114	526	486	385
Inventories	20	21	24	24	28	38	36
Receivables	57	57	60	42	76	76	118
Cash & equivalents	321	301	246	368	26	55	45

Cash flow

annual · ₹ crore · line = free cash flow

	FY24	FY25	FY26
Cash from operations	115	253	268
Cash from investing	-76	-209	-442
Cash from financing	128	301	136
Capex	85	321	502
Free cash flow	29	-67	-234
Dividends paid	6	7	7

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,321 cr52%

CWIP

₹194 cr8%

Investments

₹385 cr15%

Inventories

₹36 cr1%

Receivables

₹118 cr5%

Cash & equivalents

₹45 cr2%

Other assets

₹462 cr18%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Jupiter Life Line Hospitals Limited	9,428	287.60	50.5	5.78	11.5%

StoxGud checklist: Neutral setup · 5/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+15.0%

6 months+14.4%

1 year-7.7%

3Y CAGR+12.7%

5Y CAGR—

10Y CAGR—

50-day avg₹268.12

200-day avg₹270.71

RSI (14)83

FAQs

What is the share price of Jupiter Life Line Hospitals Limited?

Jupiter Life Line Hospitals Limited (JLHL) closed at ₹287.60 on NSE on 06 Nov 2026.

What is the market cap of Jupiter Life Line Hospitals Limited?

₹9,428 crore at the latest close.

What is the P/E ratio of Jupiter Life Line Hospitals Limited?

50.5, on trailing-twelve-month earnings from its filings.

How fast is Jupiter Life Line Hospitals Limited growing?

Jupiter Life Line Hospitals Limited: Latest-quarter revenue is up 16.0% year on year, profit down 2.1%.

How profitable is Jupiter Life Line Hospitals Limited?

On a trailing-twelve-month basis return on equity is 11.5%, return on capital employed 13.2%, operating margin 22.1%, net margin 11.5%.

How much debt does Jupiter Life Line Hospitals Limited have?

Jupiter Life Line Hospitals Limited is lightly geared: debt to equity is 0.36 with borrowings of ₹589 cr against cash of ₹45 cr (balance sheet of 2026-09-30). Operating profit covers interest 6.7 times.

Financials parsed from Jupiter Life Line Hospitals Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '23, annual from FY24, balance sheet from Sep '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.